NCT03044197View on ClinicalTrials.gov

Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

April 12, 2018

Study Completion Date

April 12, 2018

Conditions
Prostate CancerMagnetic Resonance ImagingTarget LesionFusion BiopsyClinically Significant Prostate CancerTransperineal
Interventions
DEVICE

MRI/ultrasound transperineal prostate biopsy

3-6 targeted biopsy cores from each prostate region of interest

DEVICE

transrectal ultrasound-guided prostate biopsy

12 systematic biopsy cores

Trial Locations (1)

77555

The University of Texas Medical Branch at Galveston, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT03044197 - Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy | Biotech Hunter | Biotech Hunter